In addition, elevation of RON expression has also been found in bladder, head and neck squamous cell carcinomas, breast and ovarian cancers (Maggiora et al., 2003; Lin et al., 2004; Cheng et al., 2005; Lee et al., 2005; Welm et al., 2007). Here, MST1R is linked to ovarian cancer.